BlackRock Health Sciences Term Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.37
資產淨值: 16.55
成立日期: 29/01/2020
 
分析
市值分佈:
49.01%
大市值
2.57%
中市值
0.84%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 77  
0%
 
100%
     10大 (21.47%)
代號 名稱 佔比% 持有日期
RCUSArcus Biosciences0.3731/12/2025
RVMDRevolution Medicines0.3531/12/2025
ALKSAlkermes plc0.3431/12/2025
ZLDPFZealand Pharma A/S0.3331/12/2025
ACLXArcellx0.3231/12/2025
RDNTRadNet0.3231/12/2025
DNLIDenali Therapeutics0.3031/12/2025
NVCRNovoCure Limited0.2631/12/2025
PTCTPTC Therapeutics0.2531/12/2025
NUVBNuvation Bio0.2431/12/2025
ALNYAlnylam Pharmaceuticals0.2331/12/2025
EWTXEdgewise Therapeutics0.2131/12/2025
BEAMBeam Therapeutics0.2031/12/2025
VKTXViking Therapeutics0.1931/12/2025
BMRNBioMarin Pharmaceutical0.1831/12/2025
RNAMAvidity Biosciences Inc.0.1630/09/2025
WVEWave Life Sciences Ltd0.1631/12/2025
DYNDyne Therapeutics0.1531/12/2025
IRONDisc Medicine0.1531/12/2025
OKUROnKure Therapeutics Inc0.1330/09/2025
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.